Výsledky vyhledávání - "Dauranbek Arybzhanov"

Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

Autor: Nigora Rasulova, Marat Khodjibekov, Sh. Sh. Sagdullaev, Dauranbek Arybzhanov, Vladimir Lyubshin, Valery Krylov

Publikováno v: World Journal of Nuclear Medicine, Vol 12, Iss 1, Pp 14-18 (2013)
World Journal of Nuclear Medicine

While bisphosphonates are indicated for prevention of skeletal-related events, radionuclide therapy is widely used for treatment of painful bone metastases. Combined radionuclide therapy with bisphosphonates has demonstrated improved effectiveness in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5702f9aa39cf1e53bfe921e10db84d26
http://www.wjnm.org/article.asp?issn=1450-1147

Zobrazit plný text záznamu

Effectiveness of Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience

Autor: Dauranbek Arybzhanov, Nigora Rasulova, Marat Khodjibekov, Valery Krylov, Vladimir Lyubshin

Publikováno v: World Journal of Nuclear Medicine, Vol 12, Iss 1, Pp 19-23 (2013)
World Journal of Nuclear Medicine

Breast and prostate cancer have a propensity to metastasize to bones and cause osteolysis and abnormal new bone formation. Metastases locally disrupt normal bone remodeling. Although metastases from prostate cancer have been classified as osteoblasti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa9583d3ab5a7ec4b7bf57d470af032
http://www.wjnm.org/article.asp?issn=1450-1147

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání